HIV-2 capsids distinguish high and low virus load patients in a West African community cohort
HIV-2 causes AIDS similar to HIV-1, however a considerable proportion of HIV-2 infected patients show no disease and have low plasma virus load (VL). An analysis of HIV-2 capsid (p26) variation demonstrated that proline at p26 positions 119, 159 and 178 are more frequent in lower VL subjects while n...
Saved in:
Published in | Vaccine Vol. 28; no. S2; pp. B60 - B67 |
---|---|
Main Authors | , , , , , , , , , , , , |
Format | Journal Article |
Language | English |
Published |
Netherlands
Elsevier Ltd
26.05.2010
Elsevier Limited |
Subjects | |
Online Access | Get full text |
ISSN | 0264-410X 1873-2518 1873-2518 |
DOI | 10.1016/j.vaccine.2009.08.060 |
Cover
Abstract | HIV-2 causes AIDS similar to HIV-1, however a considerable proportion of HIV-2 infected patients show no disease and have low plasma virus load (VL). An analysis of HIV-2 capsid (p26) variation demonstrated that proline at p26 positions 119, 159 and 178 are more frequent in lower VL subjects while non-proline residues at all three sites are more frequent in subjects with high VL.
In vitro replication levels of viruses bearing changes at the three sites suggested that these three residues influence virus replication by altering susceptibility to TRIM5α. These results provide new insights into HIV-2 pathogenesis. |
---|---|
AbstractList | HIV-2 causes AIDS similar to HIV-1, however a considerable proportion of HIV-2 infected patients show no disease and have low plasma virus load (VL). An analysis of HIV-2 capsid (p26) variation demonstrated that proline at p26 positions 119, 159 and 178 are more frequent in lower VL subjects while non-proline residues at all three sites are more frequent in subjects with high VL.
In vitro replication levels of viruses bearing changes at the three sites suggested that these three residues influence virus replication by altering susceptibility to TRIM5α. These results provide new insights into HIV-2 pathogenesis. Abstract HIV-2 causes AIDS similar to HIV-1, however a considerable proportion of HIV-2 infected patients show no disease and have low plasma virus load (VL). An analysis of HIV-2 capsid (p26) variation demonstrated that proline at p26 positions 119, 159 and 178 are more frequent in lower VL subjects while non-proline residues at all three sites are more frequent in subjects with high VL. In vitro replication levels of viruses bearing changes at the three sites suggested that these three residues influence virus replication by altering susceptibility to TRIM5α. These results provide new insights into HIV-2 pathogenesis. HIV-2 causes AIDS similar to HIV-1, however a considerable proportion of HIV-2 infected patients show no disease and have low plasma virus load (VL). An analysis of HIV-2 capsid (p26) variation demonstrated that proline at p26 positions 119, 159 and 178 are more frequent in lower VL subjects while non-proline residues at all three sites are more frequent in subjects with high VL.In vitroreplication levels of viruses bearing changes at the three sites suggested that these three residues influence virus replication by altering susceptibility to TRIM5α. These results provide new insights into HIV-2 pathogenesis. HIV-2 causes AIDS similar to HIV-1, however a considerable proportion of HIV-2 infected patients show no disease and have low plasma virus load (VL). An analysis of HIV-2 capsid (p26) variation demonstrated that proline at p26 positions 119, 159 and 178 are more frequent in lower VL subjects while non-proline residues at all three sites are more frequent in subjects with high VL. In vitro replication levels of viruses bearing changes at the three sites suggested that these three residues influence virus replication by altering susceptibility to TRIM5alpha. These results provide new insights into HIV-2 pathogenesis. HIV-2 causes AIDS similar to HIV-1, however a considerable proportion of HIV-2 infected patients show no disease and have low plasma virus load (VL). An analysis of HIV-2 capsid (p26) variation demonstrated that proline at p26 positions 119, 159 and 178 are more frequent in lower VL subjects while non-proline residues at all three sites are more frequent in subjects with high VL. In vitro replication levels of viruses bearing changes at the three sites suggested that these three residues influence virus replication by altering susceptibility to TRIM5alpha. These results provide new insights into HIV-2 pathogenesis.HIV-2 causes AIDS similar to HIV-1, however a considerable proportion of HIV-2 infected patients show no disease and have low plasma virus load (VL). An analysis of HIV-2 capsid (p26) variation demonstrated that proline at p26 positions 119, 159 and 178 are more frequent in lower VL subjects while non-proline residues at all three sites are more frequent in subjects with high VL. In vitro replication levels of viruses bearing changes at the three sites suggested that these three residues influence virus replication by altering susceptibility to TRIM5alpha. These results provide new insights into HIV-2 pathogenesis. HIV-2 causes AIDS similar to HIV-1, however a considerable proportion of HIV-2 infected patients show no disease and have low plasma virus load (VL). An analysis of HIV-2 capsid (p26) variation demonstrated that proline at p26 positions 119, 159 and 178 are more frequent in lower VL subjects while non-proline residues at all three sites are more frequent in subjects with high VL. replication levels of viruses bearing changes at the three sites suggested that these three residues influence virus replication by altering susceptibility to TRIM5 alpha . These results provide new insights into HIV-2 pathogenesis. |
Author | Jaye, Assan Townend, John Rowland-Jones, Sarah Nakayama, Emi E. Leligdowicz, Aleksandra Sato, Hironori Onyango, Clayton O. de Silva, Thushan Yokoyama, Masaru Shioda, Tatsuo Song, Haihan Cotten, Matthew Whittle, Hilton |
Author_xml | – sequence: 1 givenname: Clayton O. surname: Onyango fullname: Onyango, Clayton O. email: conyango@mrc.gm organization: Medical Research Council Laboratories, Fajara, Atlantic Road, P.O. Box 273, The Gambia – sequence: 2 givenname: Aleksandra surname: Leligdowicz fullname: Leligdowicz, Aleksandra email: aleksandra.leligdowicz@mail.mcgill.ca organization: Medical Research Council Laboratories, Fajara, Atlantic Road, P.O. Box 273, The Gambia – sequence: 3 givenname: Masaru surname: Yokoyama fullname: Yokoyama, Masaru email: yokoyama@nih.go.jp organization: Laboratory of Viral Genomics, Center for Pathogen Genomics, National Institute of Infectious Diseases, Tokyo 208-0011, Japan – sequence: 4 givenname: Hironori surname: Sato fullname: Sato, Hironori email: hirosato@nih.go.jp organization: Laboratory of Viral Genomics, Center for Pathogen Genomics, National Institute of Infectious Diseases, Tokyo 208-0011, Japan – sequence: 5 givenname: Haihan surname: Song fullname: Song, Haihan email: haihansong@hotmail.com organization: Department of Viral Infections, Research Institute for Microbial Diseases, Osaka University, Osaka 565-0871, Japan – sequence: 6 givenname: Emi E. surname: Nakayama fullname: Nakayama, Emi E. email: emien@biken.osaka-u.ac.jp organization: Department of Viral Infections, Research Institute for Microbial Diseases, Osaka University, Osaka 565-0871, Japan – sequence: 7 givenname: Tatsuo surname: Shioda fullname: Shioda, Tatsuo email: shioda@biken.osaka-u.ac.jp organization: Department of Viral Infections, Research Institute for Microbial Diseases, Osaka University, Osaka 565-0871, Japan – sequence: 8 givenname: Thushan surname: de Silva fullname: de Silva, Thushan email: tdesilva@mrc.gm organization: Medical Research Council Laboratories, Fajara, Atlantic Road, P.O. Box 273, The Gambia – sequence: 9 givenname: John surname: Townend fullname: Townend, John email: jtownend@mrc.gm organization: Medical Research Council Laboratories, Fajara, Atlantic Road, P.O. Box 273, The Gambia – sequence: 10 givenname: Assan surname: Jaye fullname: Jaye, Assan email: ajaye@mrc.gm organization: Medical Research Council Laboratories, Fajara, Atlantic Road, P.O. Box 273, The Gambia – sequence: 11 givenname: Hilton surname: Whittle fullname: Whittle, Hilton email: hwhittle@mrc.gm organization: Medical Research Council Laboratories, Fajara, Atlantic Road, P.O. Box 273, The Gambia – sequence: 12 givenname: Sarah surname: Rowland-Jones fullname: Rowland-Jones, Sarah email: sarah.rowland-jones@ndm.ox.ac.uk organization: Medical Research Council Laboratories, Fajara, Atlantic Road, P.O. Box 273, The Gambia – sequence: 13 givenname: Matthew surname: Cotten fullname: Cotten, Matthew email: mcotten@mrc.gm organization: Medical Research Council Laboratories, Fajara, Atlantic Road, P.O. Box 273, The Gambia |
BackLink | https://www.ncbi.nlm.nih.gov/pubmed/20510746$$D View this record in MEDLINE/PubMed |
BookMark | eNqNkl9rFDEUxYNU7Lb6EZSAD_Zlxpv_M0iVUtQWCj5Y1BcJaSbTzTqbWZOZLfvtzbhbhAWtT7kPv3Nyc06O0EHog0PoOYGSAJGvF-XaWOuDKylAXUJVgoRHaEYqxQoqSHWAZkAlLziBb4foKKUFAAhG6ifokIIgoLicoe8Xl18Kiq1ZJd8k3Pg0-HA7-jTHc387xyY0uOvv8NrHMeXJNHhlBu_CkLAP2OCvLg34rI3emoBtv1yOwQ-bPM37ODxFj1vTJfdsdx6j6w_vr88viqtPHy_Pz64KKwGGoqlaZWUFRnBghLaKG2nlTW04iEpwyRrKrRRUKiUI5QYsg8Yq0RqipLDsGL3a2q5i_3PMC-mlT9Z1nQmuH5NWjBGW5ZDJk3-SRACoGiivM_pyD130Ywz5GZrwWrGaM04z9WJHjTdL1-hV9EsTN_o-4Qy82QI29ilF12rrh5xgH4ZofKcJ6KlPvdC7PvXUp4ZKw-99xZ76_oKHdO-2OpdTX3sXdbK5NOsaH50ddNP7Bx3e7jnYzofccvfDbVz6k4VOVIP-PP216atBDYSyasrv9O8G_7HALx3z46c |
CitedBy_id | crossref_primary_10_2222_jsv_61_49 crossref_primary_10_1002_eji_201545451 crossref_primary_10_1097_COH_0b013e3283497155 crossref_primary_10_1016_j_micinf_2012_10_013 crossref_primary_10_3389_fimmu_2017_01616 crossref_primary_10_1093_ve_veac075 crossref_primary_10_1089_aid_2016_0229 crossref_primary_10_1016_j_isci_2019_100758 crossref_primary_10_1099_vir_0_058180_0 crossref_primary_10_1099_acmi_0_000087 crossref_primary_10_1371_journal_pone_0022779 crossref_primary_10_1097_QAD_0000000000001753 crossref_primary_10_1371_journal_ppat_1003352 crossref_primary_10_4103_ijmm_IJMM_20_109 crossref_primary_10_7554_eLife_39823 crossref_primary_10_1002_eji_200940295 crossref_primary_10_1002_rmv_1739 crossref_primary_10_3390_v15112236 crossref_primary_10_1186_s12977_014_0131_7 crossref_primary_10_1016_j_ebiom_2021_103258 crossref_primary_10_1093_infdis_jiu165 crossref_primary_10_1128_JVI_06126_11 crossref_primary_10_1186_1742_4690_7_72 crossref_primary_10_1371_journal_pone_0121199 crossref_primary_10_1111_cei_13280 crossref_primary_10_1586_eri_10_176 crossref_primary_10_1186_1742_4690_10_50 crossref_primary_10_1002_eji_202048931 crossref_primary_10_1128_JVI_00116_10 crossref_primary_10_1186_s12977_021_00577_x |
Cites_doi | 10.1038/ni0407-329 10.1126/science.283.5398.80 10.1016/S0969-2126(00)00507-4 10.1073/pnas.200286297 10.1126/science.1065659 10.1097/00002030-199407000-00016 10.1089/088922201750063197 10.1016/S0065-3233(03)66002-X 10.1093/molbev/msm092 10.1097/00002030-199308000-00015 10.1126/science.1140768 10.1128/JVI.68.11.7433-7447.1994 10.1128/JVI.79.10.5996-6004.2005 10.1089/08892220260387904 10.1007/BF01731581 10.1073/pnas.162299499 10.1038/nsb927 10.1126/science.1131528 10.1016/S0140-6736(85)92556-5 10.1126/science.1069660 10.1016/j.str.2005.09.010 10.1126/science.278.5339.849 10.1038/nature02915 10.1128/AAC.45.1.138-144.2001 10.1126/science.2425430 10.1172/JCI32380 10.1016/j.sbi.2008.02.001 10.1038/326662a0 10.1038/427791a 10.1097/QAD.0b013e3283021a8c 10.1097/00002030-200307040-00012 10.1073/pnas.0509996103 10.1038/nsmb.1497 10.1038/nature07746 10.1016/S0140-6736(89)92281-2 10.1128/JVI.00406-07 10.1097/00002030-200003100-00006 10.1128/JVI.72.10.7895-7899.1998 10.1128/JVI.68.8.4927-4936.1994 10.1038/nature02343 10.1126/science.1152905 10.1073/pnas.0936469100 10.1073/pnas.0404206101 10.1086/431197 10.1097/00042560-199709010-00005 10.1099/vir.0.18908-0 |
ContentType | Journal Article |
Copyright | 2009 Elsevier Ltd Elsevier Ltd Copyright (c) 2009 Elsevier Ltd. All rights reserved. Copyright Elsevier Limited May 26, 2010 |
Copyright_xml | – notice: 2009 Elsevier Ltd – notice: Elsevier Ltd – notice: Copyright (c) 2009 Elsevier Ltd. All rights reserved. – notice: Copyright Elsevier Limited May 26, 2010 |
DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM 3V. 7QL 7RV 7T2 7T5 7U9 7X7 7XB 88C 88E 8AO 8C1 8FE 8FH 8FI 8FJ 8FK 8G5 ABUWG AEUYN AFKRA AZQEC BBNVY BENPR BHPHI C1K CCPQU DWQXO FYUFA GHDGH GNUQQ GUQSH H94 HCIFZ K9- K9. KB0 LK8 M0R M0S M0T M1P M2O M7N M7P MBDVC NAPCQ PHGZM PHGZT PJZUB PKEHL PPXIY PQEST PQGLB PQQKQ PQUKI PRINS Q9U 7X8 |
DOI | 10.1016/j.vaccine.2009.08.060 |
DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed ProQuest Central (Corporate) Bacteriology Abstracts (Microbiology B) Nursing & Allied Health Database Health and Safety Science Abstracts (Full archive) Immunology Abstracts Virology and AIDS Abstracts Health & Medical Collection ProQuest Central (purchase pre-March 2016) Healthcare Administration Database (Alumni) Medical Database (Alumni Edition) ProQuest Pharma Collection Public Health Database ProQuest SciTech Collection ProQuest Natural Science Collection ProQuest Hospital Collection Hospital Premium Collection (Alumni Edition) ProQuest Central (Alumni) (purchase pre-March 2016) ProQuest Research Library ProQuest Central (Alumni) ProQuest One Sustainability ProQuest Central UK/Ireland ProQuest Central Essentials Biological Science Collection ProQuest Central Natural Science Collection Environmental Sciences and Pollution Management ProQuest One Community College ProQuest Central Proquest Health Research Premium Collection Health Research Premium Collection (Alumni) ProQuest Central Student ProQuest Research Library AIDS and Cancer Research Abstracts SciTech Premium Collection Consumer Health Database (Alumni Edition) ProQuest Health & Medical Complete (Alumni) Nursing & Allied Health Database (Alumni Edition) Biological Sciences Consumer Health Database ProQuest Health & Medical Collection Healthcare Administration Database Medical Database Research Library Algology Mycology and Protozoology Abstracts (Microbiology C) Biological Science Database Research Library (Corporate) Nursing & Allied Health Premium ProQuest Central Premium ProQuest One Academic (New) ProQuest Health & Medical Research Collection ProQuest One Academic Middle East (New) ProQuest One Health & Nursing ProQuest One Academic Eastern Edition (DO NOT USE) ProQuest One Applied & Life Sciences ProQuest One Academic ProQuest One Academic UKI Edition ProQuest Central China ProQuest Central Basic MEDLINE - Academic |
DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) Research Library Prep ProQuest Central Student ProQuest Central Essentials SciTech Premium Collection ProQuest Central China Environmental Sciences and Pollution Management ProQuest One Applied & Life Sciences ProQuest One Sustainability Health Research Premium Collection Natural Science Collection Health & Medical Research Collection Biological Science Collection ProQuest Central (New) ProQuest Medical Library (Alumni) Virology and AIDS Abstracts ProQuest Biological Science Collection ProQuest Family Health ProQuest One Academic Eastern Edition ProQuest Hospital Collection Health Research Premium Collection (Alumni) Biological Science Database ProQuest Hospital Collection (Alumni) Nursing & Allied Health Premium ProQuest Health & Medical Complete ProQuest One Academic UKI Edition ProQuest Health Management (Alumni Edition) ProQuest Nursing & Allied Health Source (Alumni) ProQuest One Academic ProQuest One Academic (New) ProQuest One Academic Middle East (New) ProQuest Health & Medical Complete (Alumni) ProQuest Central (Alumni Edition) ProQuest One Community College ProQuest One Health & Nursing Research Library (Alumni Edition) ProQuest Natural Science Collection ProQuest Pharma Collection ProQuest Family Health (Alumni Edition) ProQuest Central ProQuest Health & Medical Research Collection Health and Medicine Complete (Alumni Edition) ProQuest Central Korea Bacteriology Abstracts (Microbiology B) Algology Mycology and Protozoology Abstracts (Microbiology C) AIDS and Cancer Research Abstracts ProQuest Research Library Health & Safety Science Abstracts ProQuest Public Health ProQuest Central Basic ProQuest Health Management ProQuest Nursing & Allied Health Source ProQuest SciTech Collection ProQuest Medical Library Immunology Abstracts ProQuest Central (Alumni) MEDLINE - Academic |
DatabaseTitleList | Research Library Prep MEDLINE MEDLINE - Academic AIDS and Cancer Research Abstracts |
Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database – sequence: 3 dbid: BENPR name: ProQuest Central url: https://www.proquest.com/central sourceTypes: Aggregation Database |
DeliveryMethod | fulltext_linktorsrc |
Discipline | Medicine Veterinary Medicine Biology Pharmacy, Therapeutics, & Pharmacology |
EISSN | 1873-2518 |
EndPage | B67 |
ExternalDocumentID | 3217332391 20510746 10_1016_j_vaccine_2009_08_060 S0264410X09012389 1_s2_0_S0264410X09012389 |
Genre | Journal Article |
GeographicLocations | Guinea-Bissau Guinea Bissau |
GeographicLocations_xml | – name: Guinea-Bissau – name: Guinea Bissau |
GrantInformation_xml | – fundername: Medical Research Council grantid: MC_U190085856 – fundername: Medical Research Council grantid: G0801751 |
GroupedDBID | --- --K --M .1- .FO .GJ .~1 0R~ 123 1B1 1P~ 1RT 1~. 1~5 29Q 4.4 457 4G. 53G 5RE 5VS 7-5 71M 7RV 7X7 88E 8AO 8C1 8FE 8FH 8FI 8FJ 8G5 8P~ 9JM AAAJQ AABNK AAEDT AAEDW AAHBH AAIKJ AAKOC AALRI AAOAW AAQFI AAQXK AARKO AATTM AAXKI AAXUO AAYWO ABBQC ABFNM ABFRF ABJNI ABKYH ABMAC ABMZM ABRWV ABUWG ABWVN ABXDB ACDAQ ACGFO ACGFS ACIEU ACIUM ACPRK ACRLP ACRPL ACVFH ADBBV ADCNI ADEZE ADFRT ADMUD ADNMO ADVLN AEBSH AEFWE AEIPS AEKER AENEX AEUPX AEUYN AEVXI AEXOQ AFJKZ AFKRA AFPUW AFRAH AFRHN AFTJW AFXIZ AGCQF AGEKW AGGSO AGHFR AGQPQ AGUBO AGYEJ AHHHB AHMBA AIEXJ AIGII AIIUN AIKHN AITUG AJRQY AJUYK AKBMS AKRWK AKYEP ALMA_UNASSIGNED_HOLDINGS AMRAJ ANKPU ANZVX APXCP AQUVI ASPBG AVWKF AXJTR AZFZN AZQEC BBNVY BENPR BHPHI BKEYQ BKNYI BKOJK BLXMC BNPGV BPHCQ BVXVI CCPQU CJTIS CNWQP CS3 DWQXO EBS EFJIC EFKBS EJD EO8 EO9 EP2 EP3 F5P FDB FEDTE FGOYB FIRID FNPLU FYGXN FYUFA G-2 G-Q GBLVA GNUQQ GUQSH HCIFZ HEJ HLV HMCUK HMG HMK HMO HVGLF HX~ HZ~ IHE J1W K9- KOM L7B LK8 LUGTX LW9 M0R M0T M1P M29 M2O M41 M7P MO0 N9A NAPCQ O-L O9- O9~ OAUVE OK0 OZT P-8 P-9 P2P PC. PHGZM PHGZT PJZUB PPXIY PQGLB PQQKQ PROAC PSQYO PUEGO Q38 R2- ROL RPZ SAB SAE SCC SDF SDG SDP SES SEW SIN SNL SPCBC SSH SSI SSZ SVS T5K UKHRP UV1 WH7 WOW WUQ XPP Z5R ZGI ZXP ~G- 3V. AACTN AFCTW AFKWA AJOXV ALIPV AMFUW RIG AAIAV ABLVK ABYKQ AESVU AJBFU EFLBG LCYCR QYZTP AAYXX ACMHX ADSLC AGRNS AGWPP CITATION CGR CUY CVF ECM EIF NPM PMFND 7QL 7T2 7T5 7U9 7XB 8FK C1K H94 K9. M7N MBDVC PKEHL PQEST PQUKI PRINS Q9U 7X8 |
ID | FETCH-LOGICAL-c600t-d8f7c680a540312f74a6c6b9a40585463d24c6526775124a0c30dc75fa1765c3 |
IEDL.DBID | .~1 |
ISSN | 0264-410X 1873-2518 |
IngestDate | Fri Sep 05 08:53:41 EDT 2025 Thu Sep 04 23:21:56 EDT 2025 Wed Aug 13 09:10:30 EDT 2025 Sat May 31 02:09:25 EDT 2025 Thu Apr 24 23:00:52 EDT 2025 Tue Jul 01 03:37:47 EDT 2025 Fri Feb 23 02:28:40 EST 2024 Sun Feb 23 10:19:53 EST 2025 Tue Aug 26 17:02:18 EDT 2025 |
IsPeerReviewed | true |
IsScholarly | true |
Issue | S2 |
Keywords | Capsid TRIM5α HIV-2 |
Language | English |
License | https://www.elsevier.com/tdm/userlicense/1.0 Copyright (c) 2009 Elsevier Ltd. All rights reserved. |
LinkModel | DirectLink |
MergedId | FETCHMERGED-LOGICAL-c600t-d8f7c680a540312f74a6c6b9a40585463d24c6526775124a0c30dc75fa1765c3 |
Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 14 ObjectType-Article-2 ObjectType-Feature-1 content type line 23 |
PMID | 20510746 |
PQID | 1497394342 |
PQPubID | 105530 |
ParticipantIDs | proquest_miscellaneous_733135260 proquest_miscellaneous_1500790249 proquest_journals_1497394342 pubmed_primary_20510746 crossref_citationtrail_10_1016_j_vaccine_2009_08_060 crossref_primary_10_1016_j_vaccine_2009_08_060 elsevier_sciencedirect_doi_10_1016_j_vaccine_2009_08_060 elsevier_clinicalkeyesjournals_1_s2_0_S0264410X09012389 elsevier_clinicalkey_doi_10_1016_j_vaccine_2009_08_060 |
ProviderPackageCode | CITATION AAYXX |
PublicationCentury | 2000 |
PublicationDate | 2010-05-26 |
PublicationDateYYYYMMDD | 2010-05-26 |
PublicationDate_xml | – month: 05 year: 2010 text: 2010-05-26 day: 26 |
PublicationDecade | 2010 |
PublicationPlace | Netherlands |
PublicationPlace_xml | – name: Netherlands – name: Kidlington |
PublicationTitle | Vaccine |
PublicationTitleAlternate | Vaccine |
PublicationYear | 2010 |
Publisher | Elsevier Ltd Elsevier Limited |
Publisher_xml | – name: Elsevier Ltd – name: Elsevier Limited |
References | Monaco-Malbet, Berthet-Colominas, Novelli, Battai, Piga, Cheynet (bib27) 2000; 8 Shirakawa, Takaori-Kondo, Yokoyama, Izumi, Matsui, Io (bib26) 2008; 15 Poulsen, Kvinesdal, Aaby, Molbak, Frederiksen, Dias (bib5) 1989; 1 Towers, Bock, Martin, Takeuchi, Stoye, Danos (bib34) 2000; 97 Wilkins, Ricard, Todd, Whittle, Dias, Paulo Da Silva (bib50) 1993; 7 Stremlau, Owens, Perron, Kiessling, Autissier, Sodroski (bib32) 2004; 427 Stremlau (bib35) 2007; 318 Barin, M’Boup, Denis, Kanki, Allan, Lee (bib1) 1985; 2 Clavel, Guetard, Brun-Vezinet, Chamaret, Rey, Santos-Ferreira (bib2) 1986; 233 Tamura, Nei, Kumar (bib49) 2004; 101 Guyader, Emerman, Sonigo, Clavel, Montagnier, Alizon (bib31) 1987; 326 Brumme, Tao, Szeto, Brumme, Carlson, Chan (bib42) 2008; 22 Creighton (bib38) 1992 Berry, Jaffar, Schim van der Loeff, Ariyoshi, Harding, N’Gom (bib40) 2002; 18 Kinomoto, Yokoyama, Sato, Kojima, Kurata, Ikuta (bib24) 2005; 79 Klenerman, McMichael (bib45) 2007; 315 Norrgren, Marquina, Leitner, Aaby, Melbye, Poulsen (bib12) 1997; 16 Gao, Yue, Robertson, Hill, Hui, Biggar (bib9) 1994; 68 Leligdowicz, Yindom, Onyango, Sarge-Njie, Alabi, Cotten (bib14) 2007; 117 Gamble, Yoo, Vajdos, von Schwedler, Worthylake, Wang (bib19) 1997; 278 Baker, Sali (bib28) 2001; 294 Hall (bib22) 1999; 41 Alabi, Jaffar, Ariyoshi, Blanchard, Schim van der Loeff, Awasana (bib21) 2003; 17 Kimura (bib46) 1980; 16 Berry, Ariyoshi, Jaffar, Sabally, Corrah, Tedder (bib7) 1998; 1 Howard, Vajdos, Li, Sundquist, Hill (bib39) 2003; 10 Cowan, Hatziioannou, Cunningham, Muesing, Gottlinger, Bieniasz (bib36) 2002; 99 Moore, John, James, Christiansen, Witt, Mallal (bib41) 2002; 296 Rowland-Jones, Whittle (bib4) 2007; 8 Song, Nakayama, Yokoyama, Sato, Levy, Shioda (bib23) 2007; 81 Ponder, Case (bib29) 2003; 66 Tamura, Dudley, Nei, Kumar (bib47) 2007; 24 Lemey, Pybus, Wang, Saksena, Salemi, Vandamme (bib3) 2003; 100 Berry, Ariyoshi, Balfe, Tedder, Whittle (bib6) 2001; 17 Lee, Chu (bib30) 2001; 45 Ganser-Pornillos, Yeager, Sundquist (bib18) 2008; 18 Ganser, Li, Klishko, Finch, Sundquist (bib17) 1999; 283 Ricard, Wilkins, N’Gum, Hayes, Morgan, Da Silva (bib10) 1994; 8 Briggs, Grunewald, Glass, Forster, Krausslich, Fuller (bib16) 2006; 14 Mortuza, Haire, Stevens, Smerdon, Stoye, Taylor (bib15) 2004; 431 Ariyoshi, Jaffar, Alabi, Berry, Schim van der Loeff, Sabally (bib8) 2000; 14 Goff (bib33) 2004; 427 Bhattacharya, Daniels, Heckerman, Foley, Frahm, Kadie (bib43) 2007; 315 Saitou, Nei (bib48) 1987; 4 Kinomoto, Appiah-Opong, Brandful, Yokoyama, Nii-Trebi, Ugly-Kwame (bib25) 2005; 41 Grassly, Xiang, Ariyoshi, Aaby, Jensen, Schim van der Loeff (bib11) 1998; 72 Stremlau, Perron, Lee, Li, Song, Javanbakht (bib37) 2006; 103 Kawashima, Pfafferott, Frater, Matthews, Payne, Addo (bib44) 2009; 458 Mammano, Ohagen, Hoglund, Gottlinger (bib20) 1994; 68 Padua, Jenkins, Brown, Bootman, Paixao, Almond (bib13) 2003; 84 Monaco-Malbet (10.1016/j.vaccine.2009.08.060_bib27) 2000; 8 Stremlau (10.1016/j.vaccine.2009.08.060_bib37) 2006; 103 Rowland-Jones (10.1016/j.vaccine.2009.08.060_bib4) 2007; 8 Mammano (10.1016/j.vaccine.2009.08.060_bib20) 1994; 68 Moore (10.1016/j.vaccine.2009.08.060_bib41) 2002; 296 Tamura (10.1016/j.vaccine.2009.08.060_bib49) 2004; 101 Mortuza (10.1016/j.vaccine.2009.08.060_bib15) 2004; 431 Cowan (10.1016/j.vaccine.2009.08.060_bib36) 2002; 99 Ariyoshi (10.1016/j.vaccine.2009.08.060_bib8) 2000; 14 Kawashima (10.1016/j.vaccine.2009.08.060_bib44) 2009; 458 Shirakawa (10.1016/j.vaccine.2009.08.060_bib26) 2008; 15 Bhattacharya (10.1016/j.vaccine.2009.08.060_bib43) 2007; 315 Lee (10.1016/j.vaccine.2009.08.060_bib30) 2001; 45 Kimura (10.1016/j.vaccine.2009.08.060_bib46) 1980; 16 Gamble (10.1016/j.vaccine.2009.08.060_bib19) 1997; 278 Song (10.1016/j.vaccine.2009.08.060_bib23) 2007; 81 Padua (10.1016/j.vaccine.2009.08.060_bib13) 2003; 84 Leligdowicz (10.1016/j.vaccine.2009.08.060_bib14) 2007; 117 Ganser-Pornillos (10.1016/j.vaccine.2009.08.060_bib18) 2008; 18 Guyader (10.1016/j.vaccine.2009.08.060_bib31) 1987; 326 Kinomoto (10.1016/j.vaccine.2009.08.060_bib25) 2005; 41 Alabi (10.1016/j.vaccine.2009.08.060_bib21) 2003; 17 Towers (10.1016/j.vaccine.2009.08.060_bib34) 2000; 97 Berry (10.1016/j.vaccine.2009.08.060_bib7) 1998; 1 Wilkins (10.1016/j.vaccine.2009.08.060_bib50) 1993; 7 Klenerman (10.1016/j.vaccine.2009.08.060_bib45) 2007; 315 Ponder (10.1016/j.vaccine.2009.08.060_bib29) 2003; 66 Baker (10.1016/j.vaccine.2009.08.060_bib28) 2001; 294 Hall (10.1016/j.vaccine.2009.08.060_bib22) 1999; 41 Grassly (10.1016/j.vaccine.2009.08.060_bib11) 1998; 72 Tamura (10.1016/j.vaccine.2009.08.060_bib47) 2007; 24 Creighton (10.1016/j.vaccine.2009.08.060_bib38) 1992 Poulsen (10.1016/j.vaccine.2009.08.060_bib5) 1989; 1 Saitou (10.1016/j.vaccine.2009.08.060_bib48) 1987; 4 Lemey (10.1016/j.vaccine.2009.08.060_bib3) 2003; 100 Ganser (10.1016/j.vaccine.2009.08.060_bib17) 1999; 283 Stremlau (10.1016/j.vaccine.2009.08.060_bib32) 2004; 427 Gao (10.1016/j.vaccine.2009.08.060_bib9) 1994; 68 Briggs (10.1016/j.vaccine.2009.08.060_bib16) 2006; 14 Norrgren (10.1016/j.vaccine.2009.08.060_bib12) 1997; 16 Berry (10.1016/j.vaccine.2009.08.060_bib40) 2002; 18 Brumme (10.1016/j.vaccine.2009.08.060_bib42) 2008; 22 Ricard (10.1016/j.vaccine.2009.08.060_bib10) 1994; 8 Howard (10.1016/j.vaccine.2009.08.060_bib39) 2003; 10 Barin (10.1016/j.vaccine.2009.08.060_bib1) 1985; 2 Stremlau (10.1016/j.vaccine.2009.08.060_bib35) 2007; 318 Kinomoto (10.1016/j.vaccine.2009.08.060_bib24) 2005; 79 Goff (10.1016/j.vaccine.2009.08.060_bib33) 2004; 427 Clavel (10.1016/j.vaccine.2009.08.060_bib2) 1986; 233 Berry (10.1016/j.vaccine.2009.08.060_bib6) 2001; 17 |
References_xml | – volume: 68 start-page: 4927 year: 1994 end-page: 4936 ident: bib20 article-title: Role of the major homology region of human immunodeficiency virus type 1 in virion morphogenesis publication-title: J Virol – volume: 117 start-page: 3067 year: 2007 end-page: 3074 ident: bib14 article-title: Robust Gag-specific T cell responses characterize viremia control in HIV-2 infection publication-title: J Clin Invest – volume: 427 start-page: 791 year: 2004 end-page: 793 ident: bib33 article-title: HIV: replication trimmed back publication-title: Nature – volume: 1 start-page: 457 year: 1998 end-page: 468 ident: bib7 article-title: Low peripheral blood viral HIV-2 RNA in individuals with high CD4 percentage differentiates HIV-2 from HIV-1 infection publication-title: J Hum Virol – volume: 97 start-page: 12295 year: 2000 end-page: 12299 ident: bib34 article-title: A conserved mechanism of retrovirus restriction in mammals publication-title: Proc Natl Acad Sci USA – volume: 100 start-page: 6588 year: 2003 end-page: 6592 ident: bib3 article-title: Tracing the origin and history of the HIV-2 epidemic publication-title: Proc Natl Acad Sci USA – volume: 18 start-page: 203 year: 2008 end-page: 217 ident: bib18 article-title: The structural biology of HIV assembly publication-title: Curr Opin Struct Biol – volume: 79 start-page: 5996 year: 2005 end-page: 6004 ident: bib24 article-title: Amino acid 36 in the human immunodeficiency virus type 1 gp41 ectodomain controls fusogenic activity: implications for the molecular mechanism of viral escape from a fusion inhibitor publication-title: J Virol – volume: 22 start-page: 1277 year: 2008 end-page: 1286 ident: bib42 article-title: Human leukocyte antigen-specific polymorphisms in HIV-1 Gag and their association with viral load in chronic untreated infection publication-title: AIDS – volume: 10 start-page: 475 year: 2003 end-page: 481 ident: bib39 article-title: Structural insights into the catalytic mechanism of cyclophilin A publication-title: Nat Struct Biol – volume: 15 start-page: 1184 year: 2008 end-page: 1191 ident: bib26 article-title: Phosphorylation of APOBEC3G by protein kinase A regulates its interaction with HIV-1 Vif publication-title: Nat Struct Mol Biol – volume: 18 start-page: 1167 year: 2002 end-page: 1173 ident: bib40 article-title: Low level viremia and high CD4% predict normal survival in a cohort of HIV type-2-infected villagers publication-title: AIDS Res Hum Retroviruses – volume: 315 start-page: 1583 year: 2007 end-page: 1586 ident: bib43 article-title: Founder effects in the assessment of HIV polymorphisms and HLA allele associations publication-title: Science – volume: 16 start-page: 111 year: 1980 end-page: 120 ident: bib46 article-title: A simple method for estimating evolutionary rates of base substitutions through comparative studies of nucleotide sequences publication-title: J Mol Evol – volume: 296 start-page: 1439 year: 2002 end-page: 1443 ident: bib41 article-title: Evidence of HIV-1 adaptation to HLA-restricted immune responses at a population level publication-title: Science – volume: 81 start-page: 7280 year: 2007 end-page: 7285 ident: bib23 article-title: A single amino acid of the human immunodeficiency virus type 2 capsid affects its replication in the presence of cynomolgus monkey and human TRIM5alphas publication-title: J Virol – volume: 16 start-page: 31 year: 1997 end-page: 38 ident: bib12 article-title: HIV-2 genetic variation and DNA load in asymptomatic carriers and AIDS cases in Guinea-Bissau publication-title: J Acquir Immune Defic Syndr Hum Retrovirol – volume: 2 start-page: 1387 year: 1985 end-page: 1389 ident: bib1 article-title: Serological evidence for virus related to simian T-lymphotropic retrovirus III in residents of west Africa publication-title: Lancet – volume: 431 start-page: 481 year: 2004 end-page: 485 ident: bib15 article-title: High-resolution structure of a retroviral capsid hexameric amino-terminal domain publication-title: Nature – volume: 8 start-page: 977 year: 1994 end-page: 982 ident: bib10 article-title: The effects of HIV-2 infection in a rural area of Guinea-Bissau publication-title: AIDS – volume: 24 start-page: 1596 year: 2007 end-page: 1599 ident: bib47 article-title: MEGA4: molecular evolutionary genetics analysis (MEGA) software version 4.0 publication-title: Mol Biol Evol – volume: 41 start-page: 95 year: 1999 end-page: 98 ident: bib22 article-title: BioEdit: a user-friendly biological sequence alignment editor and analysis program for Windows 95/98/NT publication-title: Nucleic Acids Symp Ser – volume: 294 start-page: 93 year: 2001 end-page: 96 ident: bib28 article-title: Protein structure prediction and structural genomics publication-title: Science – year: 1992 ident: bib38 article-title: Proteins: Structures and Molecular Properties – volume: 427 start-page: 848 year: 2004 end-page: 853 ident: bib32 article-title: The cytoplasmic body component TRIM5alpha restricts HIV-1 infection in old World monkeys publication-title: Nature – volume: 278 start-page: 849 year: 1997 end-page: 853 ident: bib19 article-title: Structure of the carboxyl-terminal dimerization domain of the HIV-1 capsid protein publication-title: Science – volume: 8 start-page: 1069 year: 2000 end-page: 1077 ident: bib27 article-title: Mutual conformational adaptations in antigen and antibody upon complex formation between an Fab and HIV-1 capsid protein p24 publication-title: Structure – volume: 283 start-page: 80 year: 1999 end-page: 83 ident: bib17 article-title: Assembly and analysis of conical models for the HIV-1 core publication-title: Science – volume: 68 start-page: 7433 year: 1994 end-page: 7447 ident: bib9 article-title: Genetic diversity of human immunodeficiency virus type 2: evidence for distinct sequence subtypes with differences in virus biology publication-title: J Virol – volume: 72 start-page: 7895 year: 1998 end-page: 7899 ident: bib11 article-title: Mortality among human immunodeficiency virus type 2-positive villagers in rural Guinea-Bissau is correlated with viral genotype publication-title: J Virol – volume: 315 start-page: 1505 year: 2007 end-page: 1507 ident: bib45 article-title: AIDS/HIV. Finding footprints among the trees publication-title: Science – volume: 326 start-page: 662 year: 1987 end-page: 669 ident: bib31 article-title: Genome organization and transactivation of the human immunodeficiency virus type 2 publication-title: Nature – volume: 99 start-page: 11914 year: 2002 end-page: 11919 ident: bib36 article-title: Cellular inhibitors with Fv1-like activity restrict human and simian immunodeficiency virus tropism publication-title: Proc Natl Acad Sci USA – volume: 14 start-page: 15 year: 2006 end-page: 20 ident: bib16 article-title: The mechanism of HIV-1 core assembly: insights from three-dimensional reconstructions of authentic virions publication-title: Structure – volume: 8 start-page: 329 year: 2007 end-page: 331 ident: bib4 article-title: Out of Africa: what can we learn from HIV-2 about protective immunity to HIV-1? publication-title: Nat Immunol – volume: 458 start-page: 641 year: 2009 end-page: 645 ident: bib44 article-title: Adaptation of HIV-1 to human leukocyte antigen class I publication-title: Nature – volume: 1 start-page: 827 year: 1989 end-page: 831 ident: bib5 article-title: Prevalence of and mortality from human immunodeficiency virus type 2 in Bissau, West Africa publication-title: Lancet – volume: 66 start-page: 27 year: 2003 end-page: 85 ident: bib29 article-title: Force fields for protein simulations publication-title: Adv Protein Chem – volume: 101 start-page: 11030 year: 2004 end-page: 11035 ident: bib49 article-title: Prospects for inferring very large phylogenies by using the neighbour-joining method publication-title: Proc Natl Acad Sci USA – volume: 45 start-page: 138 year: 2001 end-page: 144 ident: bib30 article-title: Molecular modelling approach to understanding the mode of action of publication-title: Antimicrob Agents Chemother – volume: 103 start-page: 5514 year: 2006 end-page: 5519 ident: bib37 article-title: Specific recognition and accelerated uncoating of retroviral capsids by the TRIM5alpha restriction factor publication-title: Proc Natl Acad Sci USA – volume: 233 start-page: 343 year: 1986 end-page: 346 ident: bib2 article-title: Isolation of a new human retrovirus from West African patients with AIDS publication-title: Science – volume: 7 start-page: 1119 year: 1993 end-page: 1122 ident: bib50 article-title: The epidemiology of HIV infection in a rural area of Guinea-Bissau publication-title: AIDS – volume: 318 start-page: 1565 year: 2007 end-page: 1566 ident: bib35 article-title: GE Prize-winning essay, Why old World monkeys are resistant to HIV-1 publication-title: Science – volume: 17 start-page: 263 year: 2001 end-page: 267 ident: bib6 article-title: Sequence specificity of the human immunodeficiency virus type 2 (hiv-2) long terminal repeat u3 region in vivo allows subtyping of the principal hiv-2 viral subtypes a and b publication-title: AIDS Res Hum Retroviruses – volume: 84 start-page: 1287 year: 2003 end-page: 1299 ident: bib13 article-title: Natural variation of the Nef gene in human immunodeficiency virus type 2 infections in Portugal publication-title: J Gen Virol – volume: 17 start-page: 1513 year: 2003 end-page: 1520 ident: bib21 article-title: Plasma viral load, CD4 cell percentage, HLA and survival of HIV-1, HIV-2, and dually infected Gambian patients publication-title: AIDS – volume: 14 start-page: 339 year: 2000 end-page: 344 ident: bib8 article-title: Plasma RNA viral load predicts the rate of CD4 T cell decline and death in HIV-2-infected patients in West Africa publication-title: AIDS – volume: 41 start-page: 243 year: 2005 end-page: 251 ident: bib25 article-title: HIV-1 proteases from drug-naive West African patients are differentially less susceptible to protease inhibitors publication-title: Clin Infect Dis – volume: 4 start-page: 406 year: 1987 end-page: 425 ident: bib48 article-title: The neighbor-joining method: a new method for reconstructing phylogenetic trees publication-title: Mol Biol Evol – volume: 8 start-page: 329 issue: 4 year: 2007 ident: 10.1016/j.vaccine.2009.08.060_bib4 article-title: Out of Africa: what can we learn from HIV-2 about protective immunity to HIV-1? publication-title: Nat Immunol doi: 10.1038/ni0407-329 – volume: 283 start-page: 80 issue: 5398 year: 1999 ident: 10.1016/j.vaccine.2009.08.060_bib17 article-title: Assembly and analysis of conical models for the HIV-1 core publication-title: Science doi: 10.1126/science.283.5398.80 – volume: 8 start-page: 1069 issue: 10 year: 2000 ident: 10.1016/j.vaccine.2009.08.060_bib27 article-title: Mutual conformational adaptations in antigen and antibody upon complex formation between an Fab and HIV-1 capsid protein p24 publication-title: Structure doi: 10.1016/S0969-2126(00)00507-4 – volume: 1 start-page: 457 issue: 7 year: 1998 ident: 10.1016/j.vaccine.2009.08.060_bib7 article-title: Low peripheral blood viral HIV-2 RNA in individuals with high CD4 percentage differentiates HIV-2 from HIV-1 infection publication-title: J Hum Virol – volume: 97 start-page: 12295 issue: 22 year: 2000 ident: 10.1016/j.vaccine.2009.08.060_bib34 article-title: A conserved mechanism of retrovirus restriction in mammals publication-title: Proc Natl Acad Sci USA doi: 10.1073/pnas.200286297 – year: 1992 ident: 10.1016/j.vaccine.2009.08.060_bib38 – volume: 294 start-page: 93 issue: 5540 year: 2001 ident: 10.1016/j.vaccine.2009.08.060_bib28 article-title: Protein structure prediction and structural genomics publication-title: Science doi: 10.1126/science.1065659 – volume: 41 start-page: 95 year: 1999 ident: 10.1016/j.vaccine.2009.08.060_bib22 article-title: BioEdit: a user-friendly biological sequence alignment editor and analysis program for Windows 95/98/NT publication-title: Nucleic Acids Symp Ser – volume: 8 start-page: 977 issue: 7 year: 1994 ident: 10.1016/j.vaccine.2009.08.060_bib10 article-title: The effects of HIV-2 infection in a rural area of Guinea-Bissau publication-title: AIDS doi: 10.1097/00002030-199407000-00016 – volume: 17 start-page: 263 issue: 3 year: 2001 ident: 10.1016/j.vaccine.2009.08.060_bib6 article-title: Sequence specificity of the human immunodeficiency virus type 2 (hiv-2) long terminal repeat u3 region in vivo allows subtyping of the principal hiv-2 viral subtypes a and b publication-title: AIDS Res Hum Retroviruses doi: 10.1089/088922201750063197 – volume: 66 start-page: 27 year: 2003 ident: 10.1016/j.vaccine.2009.08.060_bib29 article-title: Force fields for protein simulations publication-title: Adv Protein Chem doi: 10.1016/S0065-3233(03)66002-X – volume: 24 start-page: 1596 issue: 8 year: 2007 ident: 10.1016/j.vaccine.2009.08.060_bib47 article-title: MEGA4: molecular evolutionary genetics analysis (MEGA) software version 4.0 publication-title: Mol Biol Evol doi: 10.1093/molbev/msm092 – volume: 7 start-page: 1119 issue: 8 year: 1993 ident: 10.1016/j.vaccine.2009.08.060_bib50 article-title: The epidemiology of HIV infection in a rural area of Guinea-Bissau publication-title: AIDS doi: 10.1097/00002030-199308000-00015 – volume: 315 start-page: 1505 issue: 5818 year: 2007 ident: 10.1016/j.vaccine.2009.08.060_bib45 article-title: AIDS/HIV. Finding footprints among the trees publication-title: Science doi: 10.1126/science.1140768 – volume: 68 start-page: 7433 issue: 11 year: 1994 ident: 10.1016/j.vaccine.2009.08.060_bib9 article-title: Genetic diversity of human immunodeficiency virus type 2: evidence for distinct sequence subtypes with differences in virus biology publication-title: J Virol doi: 10.1128/JVI.68.11.7433-7447.1994 – volume: 79 start-page: 5996 issue: 10 year: 2005 ident: 10.1016/j.vaccine.2009.08.060_bib24 article-title: Amino acid 36 in the human immunodeficiency virus type 1 gp41 ectodomain controls fusogenic activity: implications for the molecular mechanism of viral escape from a fusion inhibitor publication-title: J Virol doi: 10.1128/JVI.79.10.5996-6004.2005 – volume: 18 start-page: 1167 issue: 16 year: 2002 ident: 10.1016/j.vaccine.2009.08.060_bib40 article-title: Low level viremia and high CD4% predict normal survival in a cohort of HIV type-2-infected villagers publication-title: AIDS Res Hum Retroviruses doi: 10.1089/08892220260387904 – volume: 16 start-page: 111 issue: 2 year: 1980 ident: 10.1016/j.vaccine.2009.08.060_bib46 article-title: A simple method for estimating evolutionary rates of base substitutions through comparative studies of nucleotide sequences publication-title: J Mol Evol doi: 10.1007/BF01731581 – volume: 99 start-page: 11914 issue: 18 year: 2002 ident: 10.1016/j.vaccine.2009.08.060_bib36 article-title: Cellular inhibitors with Fv1-like activity restrict human and simian immunodeficiency virus tropism publication-title: Proc Natl Acad Sci USA doi: 10.1073/pnas.162299499 – volume: 10 start-page: 475 issue: 6 year: 2003 ident: 10.1016/j.vaccine.2009.08.060_bib39 article-title: Structural insights into the catalytic mechanism of cyclophilin A publication-title: Nat Struct Biol doi: 10.1038/nsb927 – volume: 315 start-page: 1583 issue: 5818 year: 2007 ident: 10.1016/j.vaccine.2009.08.060_bib43 article-title: Founder effects in the assessment of HIV polymorphisms and HLA allele associations publication-title: Science doi: 10.1126/science.1131528 – volume: 2 start-page: 1387 issue: 8469–70 year: 1985 ident: 10.1016/j.vaccine.2009.08.060_bib1 article-title: Serological evidence for virus related to simian T-lymphotropic retrovirus III in residents of west Africa publication-title: Lancet doi: 10.1016/S0140-6736(85)92556-5 – volume: 296 start-page: 1439 issue: 5572 year: 2002 ident: 10.1016/j.vaccine.2009.08.060_bib41 article-title: Evidence of HIV-1 adaptation to HLA-restricted immune responses at a population level publication-title: Science doi: 10.1126/science.1069660 – volume: 14 start-page: 15 issue: 1 year: 2006 ident: 10.1016/j.vaccine.2009.08.060_bib16 article-title: The mechanism of HIV-1 core assembly: insights from three-dimensional reconstructions of authentic virions publication-title: Structure doi: 10.1016/j.str.2005.09.010 – volume: 278 start-page: 849 issue: 5339 year: 1997 ident: 10.1016/j.vaccine.2009.08.060_bib19 article-title: Structure of the carboxyl-terminal dimerization domain of the HIV-1 capsid protein publication-title: Science doi: 10.1126/science.278.5339.849 – volume: 431 start-page: 481 issue: 7007 year: 2004 ident: 10.1016/j.vaccine.2009.08.060_bib15 article-title: High-resolution structure of a retroviral capsid hexameric amino-terminal domain publication-title: Nature doi: 10.1038/nature02915 – volume: 45 start-page: 138 issue: 1 year: 2001 ident: 10.1016/j.vaccine.2009.08.060_bib30 article-title: Molecular modelling approach to understanding the mode of action of l-nucleosides as antiviral agents publication-title: Antimicrob Agents Chemother doi: 10.1128/AAC.45.1.138-144.2001 – volume: 233 start-page: 343 issue: 4761 year: 1986 ident: 10.1016/j.vaccine.2009.08.060_bib2 article-title: Isolation of a new human retrovirus from West African patients with AIDS publication-title: Science doi: 10.1126/science.2425430 – volume: 117 start-page: 3067 issue: 10 year: 2007 ident: 10.1016/j.vaccine.2009.08.060_bib14 article-title: Robust Gag-specific T cell responses characterize viremia control in HIV-2 infection publication-title: J Clin Invest doi: 10.1172/JCI32380 – volume: 18 start-page: 203 issue: 2 year: 2008 ident: 10.1016/j.vaccine.2009.08.060_bib18 article-title: The structural biology of HIV assembly publication-title: Curr Opin Struct Biol doi: 10.1016/j.sbi.2008.02.001 – volume: 326 start-page: 662 issue: 6114 year: 1987 ident: 10.1016/j.vaccine.2009.08.060_bib31 article-title: Genome organization and transactivation of the human immunodeficiency virus type 2 publication-title: Nature doi: 10.1038/326662a0 – volume: 427 start-page: 791 issue: 6977 year: 2004 ident: 10.1016/j.vaccine.2009.08.060_bib33 article-title: HIV: replication trimmed back publication-title: Nature doi: 10.1038/427791a – volume: 22 start-page: 1277 issue: 11 year: 2008 ident: 10.1016/j.vaccine.2009.08.060_bib42 article-title: Human leukocyte antigen-specific polymorphisms in HIV-1 Gag and their association with viral load in chronic untreated infection publication-title: AIDS doi: 10.1097/QAD.0b013e3283021a8c – volume: 17 start-page: 1513 issue: 10 year: 2003 ident: 10.1016/j.vaccine.2009.08.060_bib21 article-title: Plasma viral load, CD4 cell percentage, HLA and survival of HIV-1, HIV-2, and dually infected Gambian patients publication-title: AIDS doi: 10.1097/00002030-200307040-00012 – volume: 103 start-page: 5514 issue: 14 year: 2006 ident: 10.1016/j.vaccine.2009.08.060_bib37 article-title: Specific recognition and accelerated uncoating of retroviral capsids by the TRIM5alpha restriction factor publication-title: Proc Natl Acad Sci USA doi: 10.1073/pnas.0509996103 – volume: 15 start-page: 1184 issue: 11 year: 2008 ident: 10.1016/j.vaccine.2009.08.060_bib26 article-title: Phosphorylation of APOBEC3G by protein kinase A regulates its interaction with HIV-1 Vif publication-title: Nat Struct Mol Biol doi: 10.1038/nsmb.1497 – volume: 458 start-page: 641 issue: 7238 year: 2009 ident: 10.1016/j.vaccine.2009.08.060_bib44 article-title: Adaptation of HIV-1 to human leukocyte antigen class I publication-title: Nature doi: 10.1038/nature07746 – volume: 1 start-page: 827 issue: 8642 year: 1989 ident: 10.1016/j.vaccine.2009.08.060_bib5 article-title: Prevalence of and mortality from human immunodeficiency virus type 2 in Bissau, West Africa publication-title: Lancet doi: 10.1016/S0140-6736(89)92281-2 – volume: 81 start-page: 7280 issue: 13 year: 2007 ident: 10.1016/j.vaccine.2009.08.060_bib23 article-title: A single amino acid of the human immunodeficiency virus type 2 capsid affects its replication in the presence of cynomolgus monkey and human TRIM5alphas publication-title: J Virol doi: 10.1128/JVI.00406-07 – volume: 14 start-page: 339 issue: 4 year: 2000 ident: 10.1016/j.vaccine.2009.08.060_bib8 article-title: Plasma RNA viral load predicts the rate of CD4 T cell decline and death in HIV-2-infected patients in West Africa publication-title: AIDS doi: 10.1097/00002030-200003100-00006 – volume: 72 start-page: 7895 issue: 10 year: 1998 ident: 10.1016/j.vaccine.2009.08.060_bib11 article-title: Mortality among human immunodeficiency virus type 2-positive villagers in rural Guinea-Bissau is correlated with viral genotype publication-title: J Virol doi: 10.1128/JVI.72.10.7895-7899.1998 – volume: 68 start-page: 4927 issue: 8 year: 1994 ident: 10.1016/j.vaccine.2009.08.060_bib20 article-title: Role of the major homology region of human immunodeficiency virus type 1 in virion morphogenesis publication-title: J Virol doi: 10.1128/JVI.68.8.4927-4936.1994 – volume: 427 start-page: 848 issue: 6977 year: 2004 ident: 10.1016/j.vaccine.2009.08.060_bib32 article-title: The cytoplasmic body component TRIM5alpha restricts HIV-1 infection in old World monkeys publication-title: Nature doi: 10.1038/nature02343 – volume: 318 start-page: 1565 issue: 5856 year: 2007 ident: 10.1016/j.vaccine.2009.08.060_bib35 article-title: GE Prize-winning essay, Why old World monkeys are resistant to HIV-1 publication-title: Science doi: 10.1126/science.1152905 – volume: 100 start-page: 6588 issue: 11 year: 2003 ident: 10.1016/j.vaccine.2009.08.060_bib3 article-title: Tracing the origin and history of the HIV-2 epidemic publication-title: Proc Natl Acad Sci USA doi: 10.1073/pnas.0936469100 – volume: 101 start-page: 11030 issue: 30 year: 2004 ident: 10.1016/j.vaccine.2009.08.060_bib49 article-title: Prospects for inferring very large phylogenies by using the neighbour-joining method publication-title: Proc Natl Acad Sci USA doi: 10.1073/pnas.0404206101 – volume: 41 start-page: 243 issue: 2 year: 2005 ident: 10.1016/j.vaccine.2009.08.060_bib25 article-title: HIV-1 proteases from drug-naive West African patients are differentially less susceptible to protease inhibitors publication-title: Clin Infect Dis doi: 10.1086/431197 – volume: 16 start-page: 31 issue: 1 year: 1997 ident: 10.1016/j.vaccine.2009.08.060_bib12 article-title: HIV-2 genetic variation and DNA load in asymptomatic carriers and AIDS cases in Guinea-Bissau publication-title: J Acquir Immune Defic Syndr Hum Retrovirol doi: 10.1097/00042560-199709010-00005 – volume: 4 start-page: 406 issue: 4 year: 1987 ident: 10.1016/j.vaccine.2009.08.060_bib48 article-title: The neighbor-joining method: a new method for reconstructing phylogenetic trees publication-title: Mol Biol Evol – volume: 84 start-page: 1287 issue: Pt 5 year: 2003 ident: 10.1016/j.vaccine.2009.08.060_bib13 article-title: Natural variation of the Nef gene in human immunodeficiency virus type 2 infections in Portugal publication-title: J Gen Virol doi: 10.1099/vir.0.18908-0 |
SSID | ssj0005319 |
Score | 2.1613548 |
Snippet | HIV-2 causes AIDS similar to HIV-1, however a considerable proportion of HIV-2 infected patients show no disease and have low plasma virus load (VL). An... Abstract HIV-2 causes AIDS similar to HIV-1, however a considerable proportion of HIV-2 infected patients show no disease and have low plasma virus load (VL).... |
SourceID | proquest pubmed crossref elsevier |
SourceType | Aggregation Database Index Database Enrichment Source Publisher |
StartPage | B60 |
SubjectTerms | Acquired immune deficiency syndrome AIDS Allergy and Immunology Antiviral Restriction Factors Capsid Capsid - virology Carrier Proteins - metabolism Cohort Studies Deoxyribonucleic acid DNA gag Gene Products, Human Immunodeficiency Virus - metabolism Guinea-Bissau HIV HIV Infections - virology HIV-2 HIV-2 - genetics HIV-2 - pathogenicity HIV-2 - physiology Human immunodeficiency virus Human immunodeficiency virus 1 Human immunodeficiency virus 2 Humans Infections Models, Molecular Patients Phylogenetics Phylogeny Plasma Polymerase chain reaction Polymorphism, Genetic RNA, Viral - genetics Sequence Analysis, Protein Studies TRIM5α Tripartite Motif Proteins Ubiquitin-Protein Ligases Viral Load Virus Replication Viruses |
SummonAdditionalLinks | – databaseName: Health & Medical Collection dbid: 7X7 link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwjV3fb9MwELZgCMTLBOVXxkCHhPa0bG7i2MkTQoipIA1Nokx5QZZjp9BpSkuTDvW_5y5xmhfKeIsUnxzl7PNn--77GHtbFs6ILI1DlyYiFE6WobECNysiMoVIHLqcCpzPv8jJN_E5T3J_4Fb7tMo-JraB2i0snZGfIpJXMZGZRe-Wv0JSjaLbVS-hcZfda6nLcDyrXA0pHnEr7IHbDPyMMc-HCp7Tq5MbY-nq2lNWEosn37U27cKe7Rp09ojte_AI7ztvP2Z3ymrE7ndykpsRe3DuL8pH7Oiio6TeHMN0qLCqj-EILgayarQZXVI-TFuUC735E_Z98ukyjMCaJQ7WGhwFgurHel7_BOI3BlM5uF78hpv5al3jk3HgCVprmFdggARroNMgqsB2RSjNBkiOd9U8ZdOzj9MPk9ALMYQW8VCDfpwpK1NuEN7F42imhJFWFplBtJcSn76LhJVJJJVC_CAMtzF3ViUzM1YysfEztlctqvIFA1NY3CDGssA2YuZmWYlNcZPMx6VBKFgETPQe0NaTlJNWxrXus9GutHccCWhmmjQ0JQ_YydZs2bF03GYge_fqvgQVg6bGdeQ2Q_U3w7L2U7_WY11HmuuvvIWaPOcZwdY0C1i6tfTopkMt_9PpYT8C9dDPdkIE7M32NQYHuvExVblYY5sEIWBGrJABgx1tSLSTRBKwl-fd4N7-wogithLy4N_9v2QP-5yKSB6yvWa1Ll8hVGuK1-18_ANKyDs- priority: 102 providerName: ProQuest |
Title | HIV-2 capsids distinguish high and low virus load patients in a West African community cohort |
URI | https://www.clinicalkey.com/#!/content/1-s2.0-S0264410X09012389 https://www.clinicalkey.es/playcontent/1-s2.0-S0264410X09012389 https://dx.doi.org/10.1016/j.vaccine.2009.08.060 https://www.ncbi.nlm.nih.gov/pubmed/20510746 https://www.proquest.com/docview/1497394342 https://www.proquest.com/docview/1500790249 https://www.proquest.com/docview/733135260 |
Volume | 28 |
hasFullText | 1 |
inHoldings | 1 |
isFullTextHit | |
isPrint | |
link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV3fb9MwELamIRAvCMqvbAMZCe1pad3EsZPHUW3qQKsqKFNfkOXYCXSa0qpJh_rC385d4rQgqIZ4SaLkTo5yl_NZvvs-Qt5mqdU8iUPfxhH3uRWZrw2HxQoPdMojCybHBufLkRh-5u-n0XSPDNpeGCyrdLG_iel1tHZ3eu5r9hazWe8Tq-dyNmUJ5gUxNvFxLtHXuz9-KfMIa3IPFPZRetvF07vu3mqD29cOthKRPNmu-WlX_lnPQ-ePySOXQNLT5h2fkL2s6JD7DaXkukMeXLrN8g45Hjew1OsTOtl2WZUn9JiOt4DVoNO5wpqYujGXtupPyZfhxZUfUKMX4LAltRgMiq-rWfmNIsYx1YWlN_Pv9Ha2XJVwpS11IK0lnRVUUyStoQ0PUUFN04hSrSlS8i6rZ2RyfjYZDH1HxuAbyIkqsGUujYiZhhQv7Ae55FoYkSYaMr4YMfVtwI2IAiEl5BBcMxMya2SU674UkQmfk_1iXmQvCdWpgUViKFKQ4bnNkwxEYaHM-pmGdDD1CG8toIwDKke-jBvVVqRdK2c4JNFMFPJoCuaR7kZt0SB13KUgWvOqtg0VAqeCueQuRfk3xax0v3-p-qoMFFN_uKhH4o3mb17-L4MetR6otuPwRIaI8Bd45M3mMQQI3PXRRTZfgUwEaWCCyJAeoTtkkLgTiRJglBeNc28-YYBRW3Jx8P-vfkgetjUXgTgi-9Vylb2CVK5KX9f_KhzlVMIxHsD1vdOLD8MRnN-djcYffwJJmkpD |
linkProvider | Elsevier |
linkToHtml | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1LbxMxEB6VVDwuCMIrUMBI0FO3dbxe7-4BIR6tEtpEEYQqF2R57Q2kqjYhm7TKj-I_MpPdTS6EcuktUjxxkrFnvll7vg_gdZo4I-PI91wUSE86lXrGSixWpDCJDBy6nBqcO13V-iY_D4LBFvyuemHoWmUVE5eB2o0tPSM_QCQf-kRmJt5NfnmkGkWnq5WERrEsjtPFJZZs-dv2J_TvGyGODvsfW16pKuBZTO4z_FLD0KqIG8QqflMMQ2mUVUlsELpERA7vhLQqECoMMRlKw63PnQ2DoWmGKrA-fuwN2JbU0FqD7Q-H3d6X9Z0Sf6kkgnUN_u4mH6xbhg7O9i-MpbPykiOTaEP5pmS4Cewuk97RPbhbolX2vlhe92Erzepws9CvXNThVqc8ma_Dbq_gwF7ssf66pSvfY7ust2bHRpv6KV3AWXYBs8r8AXxvtU89wayZ4O7ImaPIk_2Yj_KfjAiVmckcOx9fsovRdJ7jK-NYyQibs1HGDCOFHFaIHmXMFl0vswUj_d_p7CH0r8NHj6CWjbP0CTCTWKxIfZXgGDl0wzjFoViV82ZqEHsmDZCVB7QtWdFJnONcV9ffznTpOFLsjDWJdiregP2V2aSgBbnKQFXu1VXPK0ZpjYnrKsPwb4ZpXsaaXDd1LjTXX_kS2_IBjwknR3EDopVlCacKmPQ_k-5UK1Cv51ntwAa8Wr2N0YiOmEyWjuc4JkDMGRMNZQPYhjGkEkqqDDjL42Jxr_5CQSkilOrpv-d_Cbdb_c6JPml3j5_BnepCh1A7UJtN5-lzxImz5EW5Oxnoa44HfwBex3aR |
linkToPdf | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwtV1NbxMxEB2VIiouCMJXoICRoKdu4-x67d0DQogSJZRWkShVLsjy2ruQqtqEbNIqP41_x8x-JBdCufQWKZ442rFnntcz7wG8SRNnRBwFnotC4QknU89YgYcV4ZtEhA5dTg3Oxyey_018HoWjLfjd9MJQWWUTE8tA7SaW3pF3EMmrgMjM_E5Wl0UMD3vvp788UpCim9ZGTqNaIkfp8gqPb8W7wSH6-q3v9z6dfux7tcKAZzHRz_EPZsrKiBvELUHXz5Qw0sokNghjIiKKd76wMvSlUpgYheE24M6qMDNdJUMb4M_egtsqQFCFW0mN1Lq6JCg1RfCEg0-gy0fr5qHO-cGlsXRrXrNlEoEo35QWN8HeMv317sO9GreyD9VCewBbad6CO5WS5bIFO8f1HX0L9oYVG_Zyn52um7uKfbbHhmuebLRpnVEpTtkPzBrzh_C9PzjzfGbNFPdJwRzFoPzHYlz8ZEStzEzu2MXkil2OZ4sCPxnHam7Ygo1zZhhp5bBK_ihntup_mS8ZKQHP5o_g9CY89Bi280mePgVmEotn00AmOEZkLotTHIrnc95NDaLQpA2i8YC2NT86yXRc6KYQ7lzXjiPtzliTfKfkbThYmU0rgpDrDGTjXt10v2K81pjCrjNUfzNMizrqFLqrC19z_ZWXKJePeEyIOYrbEK0sa2BVAab_mXS3WYF6Pc9qL7bh9eprjEt02WTydLLAMSGiz5gIKdvANowhvVDSZ8BZnlSLe_UIfUoWSshn_57_FexgFNBfBidHz-FuU9nhy13Yns8W6QsEjPPkZbk1GegbDgV_AJ0ieVg |
openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=HIV-2+capsids+distinguish+high+and+low+virus+load+patients+in+a+West+African+community+cohort&rft.jtitle=Vaccine&rft.au=Onyango%2C+Clayton+O.&rft.au=Leligdowicz%2C+Aleksandra&rft.au=Yokoyama%2C+Masaru&rft.au=Sato%2C+Hironori&rft.date=2010-05-26&rft.pub=Elsevier+Ltd&rft.issn=0264-410X&rft.volume=28&rft.spage=B60&rft.epage=B67&rft_id=info:doi/10.1016%2Fj.vaccine.2009.08.060&rft.externalDocID=S0264410X09012389 |
thumbnail_m | http://utb.summon.serialssolutions.com/2.0.0/image/custom?url=https%3A%2F%2Fcdn.clinicalkey.com%2Fck-thumbnails%2F0264410X%2FS0264410X10X00184%2Fcov150h.gif |